Insilico Medicine and SK Biopharmaceuticals Forge $2.5 Billion AI-Driven Collaboration to Accelerate Neuroimmune Disorder Drug Discovery
In a groundbreaking advancement for pharmaceutical innovation, Insilico Medicine and SK Biopharmaceuticals have announced an ambitious AI-powered collaboration targeting neuroimmune ...
